ABSTRACT
The intradermal (ID) space has been actively explored as a means for drug delivery and diagnostics that is minimally invasive. Microneedles or microneedle patches or microarray patches (MAPs) are comprised of a series of micrometer-sized projections that can painlessly puncture the skin and access the epidermal/dermal layer. MAPs have failed to reach their full potential because many of these platforms rely on dated lithographic manufacturing processes or molding processes that are not easily scalable and hinder innovative designs of MAP geometries that can be achieved. The DeSimone Laboratory has recently developed a high-resolution continuous liquid interface production (CLIP) 3D printing technology. This 3D printer uses light and oxygen to enable a continuous, noncontact polymerization dead zone at the build surface, allowing for rapid production of MAPs with precise and tunable geometries. Using this tool, we are now able to produce new classes of lattice MAPs (L-MAPs) and dynamic MAPs (D-MAPs) that can deliver both solid state and liquid cargos and are also capable of sampling interstitial fluid. Herein, we will explore how additive manufacturing can revolutionize MAP development and open new doors for minimally invasive drug delivery and diagnostic platforms.
ABSTRACT
Implantable devices for electronically triggered drug release are attractive to achieve spatial and temporal control over drug concentrations in patients. Realization of such devices is, however, associated with technical and biological challenges. Among these are containment of drug reservoirs, lack of precise control cues, as well as the charge and size of the drug. Here, we present a method for electronically triggered release of the quaternary ammonium cation acetylcholine (ACh) from an impregnated conductive polymer film. Using supercritical carbon dioxide (scCO2), a film of PEDOT/PSS (poly(3,4)-ethylenedioxythiophene doped with poly(styrenesulfonate)) is impregnated with the neurotransmitter acetylcholine. The gentle scCO2 process generated a dry, drug-impregnated surface, well suited for interaction with biological material, while maintaining normal electrochemical properties of the polymer. Electrochemical switching of impregnated PEDOT/PSS films stimulated release of ACh from the polymer matrix, likely due to swelling mediated by the influx and efflux of charged and solvated ions. Triggered release of ACh did not affect the biological activity of the drug. This was shown by real-time monitoring of intracellular Ca2+ signaling in neurotypic cells growing on the impregnated polymer surface. Collectively, scCO2 impregnation of conducting polymers offers the first one-step, dopant-independent drug impregnation process, potentially facilitating loading of both anionic and cationic drugs that can be dissolved in scCO2 on its own or by using a co-solvent. We foresee that scCO2-loaded devices for electronically triggered drug release will create novel opportunities when generating active bio-coatings, tunable for specific needs, in a variety of medical settings.
Subject(s)
Acetylcholine/administration & dosage , Carbon Dioxide/chemistry , Neuroblastoma/metabolism , Polymers/chemistry , Acetylcholine/chemistry , Acetylcholine/metabolism , Calcium Signaling , Cell Line, Tumor , Chemistry, Pharmaceutical/methods , Drug Liberation , Humans , Polystyrenes/chemistry , Solvents/chemistry , Thiophenes/chemistrySubject(s)
Clinical Trials, Phase III as Topic , Molecular Imaging/methods , Translational Research, Biomedical , Government Regulation , Humans , Inventions , Male , Medicare/statistics & numerical data , Molecular Imaging/economics , Prostatic Neoplasms/diagnostic imaging , Surgery, Computer-Assisted , United States , United States Food and Drug AdministrationSubject(s)
Delayed-Action Preparations/chemistry , Lactic Acid/chemistry , Nanoparticles/chemistry , Polymers/chemistry , Adenosine Diphosphate/analysis , Adenosine Triphosphate/analysis , Animals , Benzothiazoles/chemistry , Benzothiazoles/pharmacokinetics , Carbon Dioxide/chemistry , Luminescent Measurements , Mice , Mice, Transgenic , Phosphates/analysis , PolyestersABSTRACT
Small interfering RNA (siRNA) is a highly potent drug in gene-based therapy with a challenge of being delivered in a sustained manner. Nanoparticle drug delivery systems allow for incorporating and controlled release of therapeutic payloads. We demonstrate that solid lipid nanoparticles can incorporate and provide sustained release of siRNA. Tristearin solid lipid nanoparticles, made by nanoprecipitation, were loaded with siRNA (4.4-5.5 wt % loading ratio) using a hydrophobic ion pairing approach that employs the cationic lipid DOTAP. Intradermal injection of these nanocarriers in mouse footpads resulted in prolonged siRNA release over a period of 10-13 days. In vitro cell studies showed that the released siRNA retained its activity. Nanoparticles developed in this study offer an alternative approach to polymeric nanoparticles for encapsulation and sustained delivery of siRNA with the advantage of being prepared from physiologically well-tolerated materials.
Subject(s)
Delayed-Action Preparations/chemistry , Nanocapsules/administration & dosage , Nanocapsules/chemistry , RNA, Small Interfering/administration & dosage , RNA, Small Interfering/chemistry , Triglycerides/chemistry , Animals , Delayed-Action Preparations/administration & dosage , Diffusion , Gene Silencing , Materials Testing , MiceABSTRACT
A general approach for producing biodegradable nanoparticles for sustained nucleic acid release is presented. The nanoparticles are produced by precipitating a water-in-oil microemulsion in supercritical CO(2). The microemulsion consists of a transfer RNA aqueous solution (water phase), dichloromethane containing poly(l-lactic acid)-poly(ethylene glycol) (oil phase), the surfactant n-octyl ß-D-glucopyranoside, and the cosurfactant n-butanol.
Subject(s)
Carbon Dioxide/chemistry , Lactates/chemistry , Nanoparticles/chemistry , Polyethylene Glycols/chemistry , RNA, Transfer/chemistry , Emulsions , Hydrogen-Ion Concentration , Thioglucosides/chemistryABSTRACT
A key challenge in developing RNAi-based therapeutics is efficient delivery of functional short interfering RNA (siRNA) to target cells. To address this need, we have used a supercritical CO(2) process to incorporate siRNA in biodegradable polymer nanoparticles (NPs) for in vivo sustained release. By this means we have obtained complete encapsulation of the siRNA with minimal initial burst effect from the surface of the NPs. The slow release of a fluorescently labeled siRNA mimic (siGLO Red) was observed for up to 80 days in vivo after intradermal injection into mouse footpads. In vivo gene silencing experiments were also performed, showing reduction of GFP signal in the epidermis of a reporter transgenic mouse model, which demonstrates that the siRNA retained activity following release from the polymer NPs.
Subject(s)
Biocompatible Materials , Nanoparticles , RNA, Small Interfering/administration & dosage , Skin , Animals , Fluorescent Dyes , Gene Silencing , Genes, Reporter , Mice , Mice, Transgenic , Microscopy, Electron, ScanningABSTRACT
Many pharmaceuticals are formulated as powders to aid drug delivery. A major problem is how to produce powders having high purity, controlled morphology, and retained bioactivity. We demonstrate the use of supercritical carbon dioxide as an antisolvent for meeting this need for two model drug systems, quercetin, a sparingly soluble antioxidant, and short interfering RNA (siRNA), which can silence genes. In both cases we achieve retention of bioactivity as well as a narrow particle size distribution in which the particles are free of impurities.